南昌大学附属第一医院病理中心学科带头人与南昌大学生物医学创新研究院副研究员。分别于四川大学生物学基地班，中国科学院武汉病毒研究所，清华大学生命联合中心获得学士，硕士（导师：陈新文研究员）与博士（导师：刘磊教授与饶子和院士）学位。2016年12月-2019年6月于四川大学生物学国家重点实验室丁楅森教授团队担任助理研究员/副研究员。2019年7月-2025年3月于西南医科大学附属中医医院担任副研究员。2025年4月于南昌大学李建明教授团队担任副研究员与病理中心学科带头人。主持肝再生与纤维化相关的国家自然科学基金面上项目2项（2021-2024，2025-2028）与青年项目（2018-2020），以及中央引导地方科技发展专项等。以第一作者/通讯作者在J. Hepatol.，PLoS Pathog.，ACS Chem. Biol.等杂志上发表SCI论文17篇。

以肝再生修复与结肠癌肝转移为对象，研究（1）局部血管重构与胆管重构的发生过程，信号调控网络与靶点干预；（2）衰老对局部血管重构与胆管重构的影响；（3）类泛素化修饰ISGylation调控网络对血管重构的影响。

1. Ying Yang^#, Yuwei Zhang^#, Lu Wang, Guanyi He, Xue Yang, Jie Qing^*. Targeting p97/ VCP promotes hepatic stellate cell senescence and mitigates liver fibrosis. DNA and Cell Biology, 2025, 44(3):132-143.

2. Xue Yang^#, Yangying Ou^#, Ying Yang, Lu Wang, Yuwei Zhang, Fulan Zhao，Pixian Shui* , Jie Qing*. Targeting endothelial coagulation signaling ameliorates liver obstructive cholestasis and dysfunctional angiogenesis. Experimental Biology and Medicine, 2023, 248(14):1242-1253.

3. Jie Qing^#, Yafeng Ren^#, Yuwei Zhang, Hua Zhang, Dongbo Wu, Yongyuan Ma, Yutian Chen, Mengli Yan, Xiaojuan Huang, Qinkai Wu, Maryam Mazhar, Li Wang, Jian Liu, Bi-Sen Ding*, Zhongwei Cao*. Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis. Journal of Hepatology, 2022, 76(2):394-406.

4. Lu Wang^#, Yuwei Zhang^#, Yafeng Ren^#, Xue Yang, Haijing Ben, Fulan Zhao, Sijin Yang, Li Wang^*, Jie Qing^*_. Pharmacological targeting of cGAS/STING -YAP axis suppresses pathological angiogenesis and ameliorates organ fibrosis, European Journal of Pharmacology, 2022, 932:175241.

5. Yuwei Zhang^#, Xue Yang^#, Tao Bi^#, Xia Wu, Lu Wang, Yafeng Ren, Yangying Ou, Chengliang Xie, Kuangjie Li, Haolong Ran, Jing Wang, Fulan Zhao, Pixian Shui, Jie Qing^*. Targeted inhibition of the immunoproteasome blocks endothelial MHC class II antigen presentation to CD4+ T Cells in chronic liver injury, International Immunopharmacology, 2022, 107:108639.

6. Han-Ying Zhu^#, Yuwei Zhang^#, Shan Su^#, Meng Wu^#, Wei Xu, Kai Chen, Lu Wang, Tong-Kuai Xi, Yan-Ni Zhang, Qin Zhou, You-Hua Xie, Lu Lu*, Jie Qing*, Ge-Min Fang*. Neutralizing SARS-CoV-2 by dimeric side chain-to-side chain cross-linked ACE2 peptide mimetics, Chemical Communications, 2022, 58(11):1804-1807.

7. Yafeng Ren^#, Yuwei Zhang^#, Lu Wang^#, Fuqian He, Mengli Yan, Xiaoheng Liu, Yangying Ou, Qinkai Wu, Tao Bi, Shiyuan Wang, Jian Liu, Bi-Sen Ding*, Li Wang*, and Jie Qing*. Selective Targeting of Vascular Endothelial YAP Activity Blocks EndMT and Ameliorates Unilateral Ureteral Obstruction-Induced Kidney Fibrosis, ACS Pharmacology & Translational Science, 2021, 4(3), 1066-1074.

8. Jie Qing, Ming Wu, Rui Luo, Jizheng Chen, Lin Cao, Debin Zeng, Luqing Shang, Junxiu Nong, Qinkai Wu, Bi-Sen Ding, Xinwen Chen*, Zihe Rao*, Lei Liu*, Zhiyong Lou*. Identification of Interferon Receptor IFNAR2 As a Novel HCV Entry Factor by Using Chemical Probes, ACS Chemical Biology, 2020, 15(5):1232-1241.

9. Jie Qing^#, Xiaoheng Liu^#, QuanWu, MengjieZhou, YuweiZhang, Maryam Mazhar, Xiaoli Huang, Li Wang, Fuqian He*. Hippo/YAP Pathway Plays a Critical Role in Effect of GDNF Against Aβ-Induced Inflammation in Microglial Cells, DNA and Cell Biology, 2020, 39(6): 1064-1071.